Crescent Grove Advisors LLC Makes New Investment in The Chemours Company (NYSE:CC)
Crescent Grove Advisors LLC acquired a new position in The Chemours Company (NYSE:CC – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 5,500 shares of the specialty chemicals company’s stock, valued at approximately $203,000. Other institutional investors and hedge funds have […]